1 results
Flaws in the U.S. Food and Drug Administration's Rationale for Supporting the Development and Approval of BiDil as a Treatment for Heart Failure Only in Black Patients
-
- Journal:
- Journal of Law, Medicine & Ethics / Volume 36 / Issue 3 / Fall 2008
- Published online by Cambridge University Press:
- 01 January 2021, pp. 449-457
- Print publication:
- Fall 2008
-
- Article
- Export citation